Remote Exercise SWEDEHEART Study
Remote Exercise SWEDEHEART Study - a Multicentre Registry-based Cluster Randomized Crossover Clinical Trial (RRCT)
Sahlgrenska University Hospital
1,500 participants
Feb 3, 2020
INTERVENTIONAL
Conditions
Summary
The overall aim of the study is to evaluate if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase participation in exCR sessions post myocardial infarction (MI).
Eligibility
Inclusion Criteria3
- Written informed consent
- Diagnosis of type 1 myocardial infarction (AMI)
- Age 18-79 years at discharge from hospital
Exclusion Criteria9
- Patients with incomplete coronary revascularization defined as at least one remaining hemodynamically significant stenosis
- Severe valve or structural heart disease
- Severe heart failure (NYHA III - IV)
- Serious arrythmias
- Inability to understand Swedish
- No internet access at home (only applicable for patients in the intervention group who wants to perform remote exCR)
- Pathological exercise test indicating high risk for adverse events during exCR
- More than 6 months between discharge form hospital and screening
- Any other condition that may interfere with the possibility for the patient to comply with the study protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.
Locations(26)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04260958